165 related articles for article (PubMed ID: 18957535)
1. Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice.
Kremen M; Krishnan R; Emery I; Hu JH; Slezicki KI; Wu A; Qian K; Du L; Plawman A; Stempien-Otero A; Dichek DA
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17109-14. PubMed ID: 18957535
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins.
Farris SD; Hu JH; Krishnan R; Emery I; Chu T; Du L; Kremen M; Dichek HL; Gold E; Ramsey SA; Dichek DA
J Biol Chem; 2011 Jun; 286(25):22665-77. PubMed ID: 21536666
[TBL] [Abstract][Full Text] [Related]
3. Level of macrophage uPA expression is an important determinant of atherosclerotic lesion growth in Apoe-/- mice.
Krishnan R; Kremen M; Hu JH; Emery I; Farris SD; Slezicki KI; Chu T; Du L; Dichek HL; Dichek DA
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1737-44. PubMed ID: 19729604
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death.
Cozen AE; Moriwaki H; Kremen M; DeYoung MB; Dichek HL; Slezicki KI; Young SG; Véniant M; Dichek DA
Circulation; 2004 May; 109(17):2129-35. PubMed ID: 15096455
[TBL] [Abstract][Full Text] [Related]
5. Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.
Hu JH; Touch P; Zhang J; Wei H; Liu S; Lund IK; Høyer-Hansen G; Dichek DA
Cardiovasc Res; 2015 Mar; 105(3):372-82. PubMed ID: 25616415
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice.
Hu JH; Du L; Chu T; Otsuka G; Dronadula N; Jaffe M; Gill SE; Parks WC; Dichek DA
Circulation; 2010 Apr; 121(14):1637-44. PubMed ID: 20351234
[TBL] [Abstract][Full Text] [Related]
7. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism.
Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.
Stempien-Otero A; Plawman A; Meznarich J; Dyamenahalli T; Otsuka G; Dichek DA
J Biol Chem; 2006 Jun; 281(22):15345-51. PubMed ID: 16554301
[TBL] [Abstract][Full Text] [Related]
9. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
[TBL] [Abstract][Full Text] [Related]
10. The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice.
Kawao N; Tamura Y; Horiuchi Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
PLoS One; 2015; 10(4):e0123982. PubMed ID: 25893677
[TBL] [Abstract][Full Text] [Related]
11. Lack of urokinase plasminogen activator promotes progression and instability of atherosclerotic lesions in apolipoprotein E-knockout mice.
Dellas C; Schremmer C; Hasenfuss G; Konstantinides SV; Schäfer K
Thromb Haemost; 2007 Jul; 98(1):220-7. PubMed ID: 17598016
[TBL] [Abstract][Full Text] [Related]
12. Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils.
Pluskota E; Soloviev DA; Bdeir K; Cines DB; Plow EF
J Biol Chem; 2004 Apr; 279(17):18063-72. PubMed ID: 14769799
[TBL] [Abstract][Full Text] [Related]
13. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
Moriwaki H; Stempien-Otero A; Kremen M; Cozen AE; Dichek DA
Circ Res; 2004 Sep; 95(6):637-44. PubMed ID: 15297377
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.
Bohnert BN; Daiminger S; Wörn M; Sure F; Staudner T; Ilyaskin AV; Batbouta F; Janessa A; Schneider JC; Essigke D; Kanse S; Haerteis S; Korbmacher C; Artunc F
Acta Physiol (Oxf); 2019 Dec; 227(4):e13286. PubMed ID: 31006168
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.
Deng GG; Martin-McNulty B; Sukovich DA; Freay A; Halks-Miller M; Thinnes T; Loskutoff DJ; Carmeliet P; Dole WP; Wang YX
Circ Res; 2003 Mar; 92(5):510-7. PubMed ID: 12600880
[TBL] [Abstract][Full Text] [Related]
17. Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.
Lugano R; Peña E; Badimon L; Padró T
J Thromb Haemost; 2012 Oct; 10(10):2158-67. PubMed ID: 22906080
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.
Ellis V; Behrendt N; Danø K
J Biol Chem; 1991 Jul; 266(19):12752-8. PubMed ID: 1829461
[TBL] [Abstract][Full Text] [Related]
20. Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis.
Chen PK; Chang BI; Kuo CH; Chen PS; Cho CF; Chang CF; Shi GY; Wu HL
FASEB J; 2013 Nov; 27(11):4520-31. PubMed ID: 23943648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
